Trial · NCT03932799
Results by group58
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 58
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Subacute Phase - More Than 7 Days of Opioids | Washington | 1.9 | % of participants | ||
| Subacute Phase - More Than 7 Days of Opioids | Ohio | 12.2 | % of participants | ||
| Chronic Phase - Composite (Meeting ≥1 of the 3 Chronic Phase Metrics) | Washington | 3-6 months | 1.2 | % of participants | |
| Chronic Phase - Composite (Meeting ≥1 of the 3 Chronic Phase Metrics) | Ohio | 3-6 months | 2.4 | % of participants | |
| Chronic Phase - Composite (Meeting ≥1 of the 3 Chronic Phase Metrics) | Washington | 6-9 months | 0.9 | % of participants | |
| Chronic Phase - Composite (Meeting ≥1 of the 3 Chronic Phase Metrics) | Ohio | 6-9 months | 2.4 | % of participants | |
| Chronic Phase - Composite (Meeting ≥1 of the 3 Chronic Phase Metrics) | Washington | 9-12 months | 0.8 | % of participants | |
| Chronic Phase - Composite (Meeting ≥1 of the 3 Chronic Phase Metrics) | Ohio | 9-12 months | 2.1 | % of participants | |
| Chronic Phase - Chronic Opioids (≥60 Days' Supply) | Washington | 3-6 months | 0.0 | % of participants | |
| Chronic Phase - Chronic Opioids (≥60 Days' Supply) | Ohio | 3-6 months | 1.7 | % of participants | |
| Chronic Phase - Chronic Opioids (≥60 Days' Supply) | Washington | 6-9 months | 0.0 | % of participants | |
| Chronic Phase - Chronic Opioids (≥60 Days' Supply) | Ohio | 6-9 months | 2.3 | % of participants | |
| Chronic Phase - Chronic Opioids (≥60 Days' Supply) | Washington | 9-12 months | 0.0 | % of participants | |
| Chronic Phase - Chronic Opioids (≥60 Days' Supply) | Ohio | 9-12 months | 1.9 | % of participants | |
| Chronic Phase - Concurrent (Concurrent Sedatives/Hypnotics and Opioids on ≥1 Day) | Washington | 3-6 months | 0.0 | % of participants | |
| Chronic Phase - Concurrent (Concurrent Sedatives/Hypnotics and Opioids on ≥1 Day) | Ohio | 3-6 months | 0.4 | % of participants | |
| Chronic Phase - Concurrent (Concurrent Sedatives/Hypnotics and Opioids on ≥1 Day) | Washington | 6-9 months | 0.0 | % of participants | |
| Chronic Phase - Concurrent (Concurrent Sedatives/Hypnotics and Opioids on ≥1 Day) | Ohio | 6-9 months | 0.1 | % of participants | |
| Chronic Phase - Concurrent (Concurrent Sedatives/Hypnotics and Opioids on ≥1 Day) | Washington | 9-12 months | 0.0 | % of participants | |
| Chronic Phase - Concurrent (Concurrent Sedatives/Hypnotics and Opioids on ≥1 Day) | Ohio | 9-12 months | 0.1 | % of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03932799/results